Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

References for PMC Articles for PubMed (Select 20647906)

1.

Race and distance effects on regular syringe exchange program use and injection risks: a geobehavioral analysis.

Williams CT, Metzger DS.

Am J Public Health. 2010 Jun;100(6):1068-74. doi: 10.2105/AJPH.2008.158337. Epub 2010 Apr 15.

2.

Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease.

Freeman CM, Martinez FJ, Han MK, Ames TM, Chensue SW, Todt JC, Arenberg DA, Meldrum CA, Getty C, McCloskey L, Curtis JL.

Am J Respir Crit Care Med. 2009 Dec 15;180(12):1179-88. doi: 10.1164/rccm.200904-0552OC. Epub 2009 Sep 3.

3.

Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1.

Tiemessen CT, Shalekoff S, Meddows-Taylor S, Schramm DB, Papathanasopoulos MA, Gray GE, Sherman GG, Coovadia AH, Kuhn L.

J Immunol. 2009 May 15;182(10):5914-8. doi: 10.4049/jimmunol.0900419.

4.

Retention of viability, cytotoxicity, and response to IL-2, IL-15, or IFN-alpha by human NK cells after CD107a degranulation.

Tomescu C, Chehimi J, Maino VC, Montaner LJ.

J Leukoc Biol. 2009 May;85(5):871-6. doi: 10.1189/jlb.1008635. Epub 2009 Feb 23.

5.

HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.

Tempalski B, Lieb S, Cleland CM, Cooper H, Brady JE, Friedman SR.

J Urban Health. 2009 Jan;86(1):132-54. doi: 10.1007/s11524-008-9328-1. Epub 2008 Nov 18.

6.

Estimation of HIV incidence in the United States.

Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS; HIV Incidence Surveillance Group.

JAMA. 2008 Aug 6;300(5):520-9. doi: 10.1001/jama.300.5.520.

7.

A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection.

Boulet S, Kleyman M, Kim JY, Kamya P, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF.

AIDS. 2008 Jul 31;22(12):1487-91. doi: 10.1097/QAD.0b013e3282ffde7e.

PMID:
18614872
8.

KIR locus polymorphisms: genotyping and disease association analysis.

Martin MP, Carrington M.

Methods Mol Biol. 2008;415:49-64. doi: 10.1007/978-1-59745-570-1_3.

PMID:
18370147
9.

Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals.

Boulet S, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF.

AIDS. 2008 Mar 12;22(5):595-9. doi: 10.1097/QAD.0b013e3282f56b23.

PMID:
18317000
10.

Morphine withdrawal dramatically reduces lymphocytes in morphine-dependent macaques.

Weed MR, Carruth LM, Adams RJ, Ator NA, Hienz RD.

J Neuroimmune Pharmacol. 2006 Sep;1(3):250-9. Epub 2006 Jul 14.

PMID:
18040802
11.

Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.

Ballan WM, Vu BA, Long BR, Loo CP, Michaëlsson J, Barbour JD, Lanier LL, Wiznia AA, Abadi J, Fennelly GJ, Rosenberg MG, Nixon DF.

J Immunol. 2007 Sep 1;179(5):3362-70.

12.
13.

Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease.

Boyton RJ, Altmann DM.

Clin Exp Immunol. 2007 Jul;149(1):1-8. Epub 2007 May 22. Review.

14.

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, Goedert JJ, Buchbinder S, Kirk GD, Telenti A, Connors M, O'Brien SJ, Walker BD, Parham P, Deeks SG, McVicar DW, Carrington M.

Nat Genet. 2007 Jun;39(6):733-40. Epub 2007 May 13.

15.

Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals.

Ravet S, Scott-Algara D, Bonnet E, Tran HK, Tran T, Nguyen N, Truong LX, Theodorou I, Barré-Sinoussi F, Pancino G, Paul P.

Blood. 2007 May 15;109(10):4296-305. Epub 2007 Feb 1.

16.

Differential dysfunction in dendritic cell subsets during chronic HCV infection.

Averill L, Lee WM, Karandikar NJ.

Clin Immunol. 2007 Apr;123(1):40-9. Epub 2007 Jan 17.

17.

Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.

Ugen KE, Nyland SB.

Springer Semin Immunopathol. 2006 Nov;28(3):281-7. Epub 2006 Oct 13. Review.

PMID:
17109182
18.

HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.

Altfeld M, Kalife ET, Qi Y, Streeck H, Lichterfeld M, Johnston MN, Burgett N, Swartz ME, Yang A, Alter G, Yu XG, Meier A, Rockstroh JK, Allen TM, Jessen H, Rosenberg ES, Carrington M, Walker BD.

PLoS Med. 2006 Oct;3(10):e403.

19.

Drug abuse, innate immunity and hepatitis C virus.

Zhang T, Li Y, Ho WZ.

Rev Med Virol. 2006 Sep-Oct;16(5):311-27. Review.

PMID:
16933366
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk